Feedback PLC (AIM:FDBK) reported strong sales momentum over the past twelve months led by its mobile-based medical imaging product Bleepa.
At the start of the month, AIM-listed Feedback flagged that trading was materially ahead of expectations and confirmed today that revenues in the year to May rose 105% to £0.59mln.
Sales jumped 280% to £0.67mln helped also by technology license fees from a partnership with Imaging Engineering utilising the Cadran platform imaging technology behind Bleepa.
Contract wins with veterinary provider CVS and two NHS acute trusts were highlights of the year, it said, as well as a pilot scheme with Sussex Health and Care for care services.
A cloud-based TB screening pilot service also went live in India in March.
Cash and cash equivalents at the year-end were £10.30m reflecting a fundraise in November.